Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Interv Cardiol Clin ; 13(2): 155-165, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38432759

RESUMO

Degenerative mitral regurgitation (DMR) has earned great interest because of modern and innovative technologies emerging in its treatment. MR affects roughly one-tenth of those older adults over the age of 75. MR if untreated leads to adverse heart remodeling, resulting in left ventricular dysfunction, pulmonary hypertension, and heart failure syndrome. Despite surgical valve repair/replacement treatment being the standard of care, a significant proportion of severe MR patients face unmet clinical needs because of high or prohibitive surgical risks. This has led to the emergence of transcatheter therapies for high- and prohibitive-risk surgical patients, most notably mitral transcatheter edge-to-edge repair devices.


Assuntos
Insuficiência Cardíaca , Hipertensão Pulmonar , Insuficiência da Valva Mitral , Disfunção Ventricular Esquerda , Humanos , Idoso , Insuficiência da Valva Mitral/cirurgia , Insuficiência Cardíaca/cirurgia , Tecnologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa